rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
26
|
pubmed:dateCreated |
2002-12-24
|
pubmed:abstractText |
We present a structural model for amyloid fibrils formed by the 40-residue beta-amyloid peptide associated with Alzheimer's disease (Abeta(1-40)), based on a set of experimental constraints from solid state NMR spectroscopy. The model additionally incorporates the cross-beta structural motif established by x-ray fiber diffraction and satisfies constraints on Abeta(1-40) fibril dimensions and mass-per-length determined from electron microscopy. Approximately the first 10 residues of Abeta(1-40) are structurally disordered in the fibrils. Residues 12-24 and 30-40 adopt beta-strand conformations and form parallel beta-sheets through intermolecular hydrogen bonding. Residues 25-29 contain a bend of the peptide backbone that brings the two beta-sheets in contact through sidechain-sidechain interactions. A single cross-beta unit is then a double-layered beta-sheet structure with a hydrophobic core and one hydrophobic face. The only charged sidechains in the core are those of D23 and K28, which form salt bridges. Fibrils with minimum mass-per-length and diameter consist of two cross-beta units with their hydrophobic faces juxtaposed.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-10048925,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-10212241,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-10212983,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-10212987,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-10354415,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-10413470,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-10547528,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-10727245,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-10940227,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-11069287,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-11076514,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-11472123,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-11570876,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-11891310,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-11960014,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-12036340,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-12093917,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-12124300,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-12391326,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-12484785,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-12525689,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-1420187,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-1453457,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-1497327,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-2002499,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-2346740,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-6375662,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-7548083,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-7881273,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-8043280,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-8428986,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-8457674,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-8502992,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-8555200,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-8609998,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-8899741,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-9356260,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-9427660,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-9449354,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-9492738,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-9796824,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12481027-9811813
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0027-8424
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
24
|
pubmed:volume |
99
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
16742-7
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:12481027-Amino Acid Sequence,
pubmed-meshheading:12481027-Amyloid beta-Peptides,
pubmed-meshheading:12481027-Humans,
pubmed-meshheading:12481027-Models, Molecular,
pubmed-meshheading:12481027-Molecular Sequence Data,
pubmed-meshheading:12481027-Nuclear Magnetic Resonance, Biomolecular,
pubmed-meshheading:12481027-Peptide Fragments,
pubmed-meshheading:12481027-Protein Structure, Secondary
|
pubmed:year |
2002
|
pubmed:articleTitle |
A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR.
|
pubmed:affiliation |
Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-0520, USA.
|
pubmed:publicationType |
Journal Article
|